主要参考文献
主要参考文献
第一章
[1]World Health Organization.World Health Day 1997 Information Kit.Revista Panamericana De Salud Pública,1997,1(3-4):476-480.
[2]Jones KE,Patel NG,Levy MA,et al.Global trends in emerging infectious diseases.Nature,2008,451(7181):990-993.
[3]Su JR.Emerging viral infection.Clin Lab Med,2004,24(2):773-775.
[4]GooF,Bcviles E,Robertson DL,et al.Origin of HIV-1 in the Chimpanzee Pan troglodytes troglodytes.Nature,1999,397(6718):436-441.
[5]Wolfe ND,Daszak P,Kilpatrick AM,et al.Bushmeat hunting,deforestation,and prediction of zoonoses emergence.Emerg Infect Dis,2005,11(12):1822-1827.
[6]Morens DM,Folkers GK,Fauci AS.The challenge of emerging and re-emerging infectious diseases.Nature,2010;463(7277):122.
[7]McGuigan H.Global Health and Emerging Infectious Diseases.J Emerg Nurs.2016;42(3):272-275.
[8]邵家胜,卢洪洲.新发传染病研究综述.诊断学理论与实践,2011,10(3):293-296.
第二章
[1]程颖,刘军,李昱,等.埃博拉病毒病:病原学、致病机制、治疗与疫苗研究进展.科学通报,2014,59(30):2889-2899.
[2]高海女,姚航平,杨仕贵,等.从SARS到MERS:证据与展望.中华临床感染病杂志,2015,8(4):292-297.
[3]耿兴义,张济,贾堂宏,等.中东呼吸综合征最新研究进展.山东大学学报(医学版),2014,52(7):106-108.
[4]顾金祥,宋明昌.黄热病.上海:上海科技教育出版社,1997.
[5]顾时平,吴雪,周斌,等.浙江省一起发热伴血小板减少综合征聚集性疫情调查.中华流行病学杂志,2015,36(4):364-367.
[6]郭丽霞,陈继明,曲光刚,等.尼帕病毒病及其病原的研究进展.中国兽医科学,2006,36(11):940-944.[7]国家卫生和计划生育委员会.埃博拉出血热防控方案(第3版).2014.
[8]国家卫生和计划生育委员会.寨卡病毒病诊疗方案(2016年第2版).2016.
[9]国家卫生和计划生育委员会.关于印发《人感染H7N9禽流感诊疗方案(2013年第2版)》的通知.2013.
[10]国家卫生和计划生育委员会.国家黄热病诊疗方案(2016年版).http://www.nhfpc.gov.cn.
[11]国家卫生和计划生育委员会.黄热病防控方案(2016年版).http://www.nhfpc.gov.cn.
[12]国家卫生和计划生育委员会.人感染H7N9禽流感诊疗方案(2014年版).中华临床感染病杂志,2014,7(1):1-3.
[13]国家卫生和计划生育委员会.中东呼吸综合征病例诊疗方案(2015年版).2015.
[14]国家卫生和计划生育委员会.中东呼吸综合征疫情防控方案(第2版).2015.
[15]Heymann LD.冯子健译.传染病控制手册.第18版.北京:中国协和医科大学出版社,2008.
[16]李国华,夏咸柱.埃博拉病毒研究进展.石河子大学学报:自然科学版,2016:3(34):265-269.
[17]李兰娟,任红.传染病学.北京:人民卫生出版社,2013.
[18]林长缨,贺雄.SARS病原学和流行病学研究进展——“非典”疫情10年回顾.国际病毒学杂志,2013,20(6):241-245.
[19]刘高山,谭文杰.中东呼吸综合征冠状病毒流行病学进展.中华微生物学与免疫学杂志,2016,36(2):81-87.
[20]刘克洲,陈智.人类病毒性疾病.第2版.北京:人民卫生出版社,2010.
[21]马亦林.中东呼吸综合征冠状病毒与人类感染.中华临床感染病杂志,2013,6(4):197-199.
[22]潘孝彰.新发传染病.北京:人民卫生出版社,2008.
[23]任瑞琦,周蕾,向妮娟,等.中国内地人感染H7N9禽流感疫情流行病学特征分析.2014,35(12):1362-1365.
[24]宋建德,袁丽萍,秦建国,等.中东呼吸综合征的流行与研究进展.2015,32(7):1-7.
[25]田丽丽,吴钶,孙玉兰,等.中国首例输人性裂谷热病例的流行病学调查.国际病毒学杂志,2016,23(6):361-363.
[26]卫生部.西尼罗热预防控制技术指南.2008.
[27]卫生部.西尼罗热诊断和治疗方案.2008.
[28]卫生部.卫生部办公厅关于印发埃博拉出血热等6种传染病预防控制指南和临床诊疗方案的通知.附件5:埃博拉出血热预防控制指南和治疗方法.2008.
[29]魏荣,王志亮,李其平,等.在中国可以传播西尼罗河病毒的蚊虫种类.中国媒介生物学及控制杂志,2004,(1):65-66.
[30]易波,曹明华.SARS流行病学及预防控制研究进展.海峡预防医学杂志,2008,14(1):30-32.
[31]中国疾病预防控制中心.登革热媒介伊蚊控制指南(2014年).2014.
[32]中国疾病预防控制中心.黄热病基本知识.http://www.chinacdc.cn.
[33]卫生部.卫生部办公厅关于印发埃博拉出血热等6种传染病预防控制指南和临床诊疗方案的通知.附件3:拉沙热预防控制指南和拉沙热诊断和治疗方案.2008.
[34]卫生部.卫生部办公厅关于印发埃博拉出血热等6种传染病预防控制指南和临床诊疗方案的通知.附件4:裂谷热预防控制指南和裂谷热诊断和治疗方案.2008.
[35]国家质量监督检验检疫局.国境口岸拉沙热疫情监测规程.2011.
[36]卫生部.传染性非典型肺炎(SARS)诊疗方案(2004版).2004.
[37]卫生部.发热伴血小板减少综合征防治指南(2010版).
[38]卫生部.人间传染的病原微生物名录.2006.
[39]Abbink P,Larocca RA,Dela Barrera RA,et al.Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.Science,2016,353(6304):1129-1132.
[40]Akahata W,Yang ZY,Andersen H,et al.A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection.Nat Med,2010,16(3):334-338.
[41]Al-Hamdan NA,Panackal AA,AlBassam TH,et al.The risk of nosocomial transmission of rift valley fever.PLOS Neglected Tropical Diseases,2015,9(12):e0004314.
[42]Arroyo J,Miller C,Catalan J,et al.ChimeriVax-West Nile viruslive-attenuated vaccine:preclinical evaluation of safety,immunogenicity,and efficacy.J Virol,2004,78(22):12497-12507.
[43]Azeez-Akande O.A Review of Lassa Fever,an Emerging Old World Haemorrhagic Viral Disease in Sub-saharan Africa.Afr J Cln.Exper.Microbiol,2016,17(4):282-289.
[44]Bai F,Wang T,Pal U,et al.Use of RNA interference to prevent lethal murine west nile virus infection.J Infect Dis,2005,191(7):1148-1154.
[45]Balenghien T,Cardinale E,Chevalier V,et al.Towards a better understanding of Rift Valley fever epidemiology in the south-west of the Indian Ocean.Veterinary Research,2013,44:78.
[46]Bao CJ,Guo XL,Qi X,et al.A family cluster of infections by a newly recognized bunyavirus in eastern China,2007:further evidence of person-to-person transmission.Clin Infect Dis,2011,53(12):1208-1214.
[47]Barba SG,Dejni RW,Rouvinski A,et al.Structural basis of potent Zika-dengue virus antibody crossneutralization.Nature,2016,536(7614):48-53.
[48]Beasley DW,Mcauley AJ,Bente DA.Yellow fever virus:genetic and phenotypic diversity and implications for detection,prevention and therapy.Antiviral Res,2015,115:48-70.
[49]Brauburger K,Hume AJ,Mühlberger E,et al.Forty-five years of Marburg virus research.Viruses,2012,4(10):1878-1927.
[50]Brian T.Evaluation of infants born to mothers with West Nile virus infection.American Family Physician,2004,7(70):204.
[51]Brosh-Nissimov T.Lassa fever:another threat from West Africa.Disaster Mil Med,2016,2:8.
[52]Calvet G,Aguiar RS,Melo AS,et al.Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil:a case study.Lancet Infect Dis,2016,16(6):653-660.
[53]Calvet,G,Aguiar,RS,Melo,AS,et al.Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil:a case study.Lancet Infect Dis,2016,S1473-3099(16)00095-5.
[54]Cao-Lormeau VM,Blake A,Mons S,et al.Guillain-BarréSyndromeoutbreak associated with Zika virus infection in French Polynesia:a case-control study.Lancet,2016;published online Feb 29.
[55]Casals J,Whitman L.Mayaro virus:a new human disease agent.I.Relationship to other arbor viruses.Am J Trop Med Hyg,1957,6(6):1004-1011.
[56]Centers for Disease Control and Prevention.2017.(https://www.cdc.gov./)
[57]Centers for Disease Control and Prevention.Ebola.2014.(https://www.cdc.gov./)
[58]Centers for disease control and prevention.Hendra Virus Disease(HeV).2014.(http://www.cdc.gov./)
[59]Centers for Disease Control and Prevention.Lassa fever.2016.(http://www.cdc.gov./)
[60]Centers for disease control and prevention.Nipah Virus(NiV).2014.(http://www.cdc.gov./)
[61]Centers for Disease Control and Prevention.Rift Valley Fever.2017.(http://www.cdc.gov./)
[62]Chapa JB,Ahn JT,DiGiovanni LM,et al.West Nile virus encephalitis during pregnancy.Obstet Gynecol,2003,102(2):229.
[63]Chen JM,Guo LX,Sun CY,et al.A stable and differentiable RNA positive control for reverse transcription-polymerase chain reaction.Biotechnol Lett,2006,28(22):1787-1792.
[64]Chen JM,Yu M,Morrissy C,et al.A comparative indirect ELISA for the detection of henipavirus antibodies based on a recombinant nucleocapsid protein expressed in Escherichia coli.J Virol Methods,2006,136(1-2):273-276.
[65]Claas EC,Osterhaus AD,van Beek R,et al.Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.Lancet,1998,351:472-477.
[66]Falzarano D,Feldmann H.Vaccines for Viral Hemorrhagic Fevers—Progress and Shortcomings.Curr Opin Virol,2013,3(3):343-351.
[67]Gao R,Cao B,Hu Y,et al.Human infection with a novel avian-origin influenza A(H7N9)virus.N Engl J Med,2013,368(20):1888-1897.
[68]Garske T,Van Kerkhove MD,Yactayo S,et al.Yellow Fever in Africa:estimating the burden of disease and impact of mass vaccination from outbreak and serological data.PLoS Med,2014,11(5):e1001638.
[69]Gong Z,Gu S,Zhang Y,et al.Probable aerosol transmission of severe fever with thrombocytopenia syndrome virus in southeastern China.Clin Microbiol Infect,2015,21(12):1115-1120.
[70]Green A.Yellow fever continues to spread in Angola.Lancet,2016,387(10037):2493.
[71]Hall RA,Nisbet DJ,Pham KB,et al.DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus.Proc Natl Acad Sci USA,2003,100(18):10460-10464.
[72]Hassan OA,Ahlm C,Evander M,et al.A need for One Health approach lessonslearned from outbreaks of Rift Valley fever in Saudi Arabia and Sudan.Infection Ecology and Epidemiology,2014,4.
[73]Heymann LD.Control of communicable diseases manual.20th edition.American Public Health Association,2014.
[74]Higgs S.Yellow Fever Virus:Cause for Concern or Alarm?Vector Borne Zoonotic Dis,2016,16(8):499-500.
[75]Ho K,Ang LW,Tan BH,et al.Epidemiology and control of chikungunya fever in Singapore.J Infect,2011,62(4):263-270.
[76]Hu B,Zeng LP,Yang XL,et al.Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.PLoS Pathog,2017,13(11):e1006698.
[77]Huang CY,Silengo SJ,Whiteman MC,et al.Chimeric dengue 2PDK-53 West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect miceagainst lethal challenge with West Nile virus.J Virol,2005,79(12):7300-7310.
[78]Ikegami T,Makino S.The Pathogenesis of Rift Valley Fever.Viruses,2011,3(5),493-519.
[79]Kim WY,Choi W,Park SW,et al.Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea.Clin Infect Dis,2015,60(11):1681-1683.
[80]Koh WL,Ng ML.Molecular mechanisms of West Nile virus pathogenesis in brain cells.Emerg Infect Dis,2005,11(4):629-632.
[81]Ksiazek TG,Rota PA,Rollin PE.A review of Nipah and Hendra viruses with an historical aside.Virus Res,2011,162(1-2):173-183.
[82]Li Z,Bao C,Hu J,et al.Ecology of the Tick-Borne Phlebovirus Causing Severe Fever with Thrombocytopenia Syndrome in an Endemic Area of China.PLoS Negl Trop Dis,2016,10(4):e4574.
[83]Liu JW,Wen HL,Fang LZ,et al.Prevalence of SFTSV among Asian house shrews and rodents,China,January-August 2013.Emerg Infect Dis,2014,20(12):2126-2128.
[84]Lu S,Zheng Y,Li T,et al.Clinical Findings for Early Human Cases of Influenza A(H7N9)Virus Infection,Shanghai,China.Emerg Infect Dis,2013,19(7):1142-1146.
[85]Lucey D,Gostin LO.A Yellow Fever Epidemic:A New Global Health Emergency?JAMA,2016,315(24):2661-2662.
[86]Lumley S,Horton DL,Hernandez-Triana LLM,et al.Rift Valley fever virus:strategies for maintenance,survival and vertical transmission in mosquitoes.J Gen Virol,2017,98(5):875-887.
[87]Lumsden WH.An epidemic of virus disease in Southern Province,Tanganyika Territory,in 1952-1953.II.General description and epidemiology.Trans R Soc Trop Med Hyg,1955,49(1):33-57.
[88]Luo LM,Zhao L,Wen H L,et al.Haemaphysalis longicornis Ticks as Reservoir and Vector of Severe Fever with Thrombocytopenia Syndrome Virus in China.Emerg Infect Dis,2015,21(10):1770-1776.
[89]Mahalingam S,Herrero LJ,Playford EG,et al.Hendra virus:an emerging paramyxovirus in Australia.Lancet Infect Dis,2012,12(10):799-807.
[90]Monath TP,Vasconcelos PF.Yellow fever.J Clin Virol,2015,64:160-173.
[91]Moore,DL,Causey OR,Care DE,et al.Arthropod-borne viral infection of man in Nigeria,1964-1970.Ann Trop Med Parasitol,1975,69(1):49-64.
[92]Murphy FA.The Foundations of Virology-Discoverers and Discoveries,Inventors and Inventions,Developers and Technologies.The United States of America:Infinity Publishing,2016.
[93]Mylnea AQ,Pigottb DM.,Longbottom J.Mapping the zoonotic niche of Lassa fever in Africa.Trans R Soc Trop Med Hyg,2015,109(8):483-492.
[94]Nakoune E,Kamgang B,Berthet N,et al.Rift Valley Fever Virus Circulating among Ruminants,Mosquitoes and Humans in the Central African Republic.PLOS Neglected Tropical Diseases,2016,10(10):e0005082.
[95]Nanyingi MO,Munyua P,Kiama SG,et al.A systematic review of Rift Valley Fever epidemiology 1931-2014.Infection Ecology and Epidemiology,2015,5:28024.
[96]NiuG,Li J,Liang M,et al.Severe fever with thrombocytopenia syndrome virus among domesticated animals,China.Emerg Infect Dis,2013,19(5):756-763.
[97]PAHO WHO.Chikungunya 2017 PAHO/WHO Data,Maps and Statistics.2017-7-15.
[98]Patrcia B,Jose P,Claudia RG,et al.Zika Virus infection in pregnant womenin Rio de Janeiropreliminary report.The new England journal of medicine,2016,March 4.
[99]Pialoux G,Gauzere BA,Jaureguiberry S,et al.Chikungunya,an epidemic arbovirosis.Lancet Infect Dis,2007,7(5):319-327.
[100]Roehlin I,Ginsberg HS,Campbell SR,et al.Distribution and abundance of host-seeking Culexspecies at three proximate locations with different levels of West Nile virus activity.Am J Trop Med Hyg,2009,80(4):661-668.
[101]Saito T,Fukushima K,Umeki K,et al.Severe fever with thrombocytopenia syndrome in Japan and public health communication.Emerg Infect Dis,2015,21(3):487-489.
[102]Satterfield BA,Dawes BE,Milligan GN.Status of vaccine research and development of vaccines for Nipah virus.Vaccine,2016,34(26):2971-2975.
[103]Shao JJ,Liang YY and Ly H.Human Hemorrhagic Fever Causing Arenaviruses:Molecular Mechanisms Contributing to Virus Virulence and Disease Pathogenesis.Pathogens,2015,4(2),283-306.
[104]Simon F,Savini H,Parola P.Chikungunya:a paradigm of emergence and globalization of vectorborne diseases.Med Clin North Am,2008,92(6):1323-1343.
[105]Stephenson I,Heath A,Major D,et al.Reproducibility of serologic assays for influenza virus A(H5N1).Emerge Infect Dis,2009,15(8):1252-1259.
[106]Subbarao K,Shaw MW.Molecular aspect of avian influenza(H5N1).viruses isolated from human.Rev Med Virol,2000,10:337-348.
[107]Sun J,Tang Y,Ling F,et al.Genetic Susceptibility Is One of the Determinants for Severe Fever with Thrombocytopenia Syndrome Virus Infection and Fatal Outcome:An Epidemiological Investigation.PLoSOne,2015,10(7):e132968.
[108]Suwannakarn K,Theamboonlers A,Poovorawan Y.Molecular genome tracking of East,Central and South African genotype of Chikungunya virus in South-east Asia between 2006 and 2009.Asian Pac J Trop Med,2011,4(7):535-540.
[109]Takasaki T,Yabe S,Nerome R,et al.Partial protective effect ofinactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice.Vaccine,2003,21(31):4514-4518.
[110]Tang X,Wu W,Wang H,et al.Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood.J Infect Dis,2013,207(5):736-739.
[111]Tong S,Zhu X,Li Y,et al.New world bats harbor diverse influenza A viruses.PLoS Pathog,2013,9(10):e1003657.
[112]Wang T,Town T,Alexopoulou L,et al.Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.Nat Med,2004,10(12):1366-1373.
[113]Wasserman S,Tambyah PA,Lim PL.Yellow fever cases in Asia:primed for an epidemic.Int J Infect Dis,2016,48:98-103.
[114]WHO Regional Office for South-East Asia.A brief guide to emerging infectious diseases and zoonoses.2014.http://apps.searo.who.int/PDS_DOCS/B5123.pdf.
[115]WHO Regional Office for South-East Asia.Nipah virus infection.2009.http://apps.searo.who.int/PDS_DOCS/B4220.pdf.
[116]WHO.MERS-CoV.2016.
[117]WHO.Prevention of sexual transmission of Zika virus Interim guidance.2016-9.(http://www.who.int/)
[118]World Health Organisation.Yellow fever.(http://who.int/)
[119]World Health Organization.Clinical management of patients with viral hemorrhagic fever.A pocket guide forfront-line health workers.Interim emergency guidance for country adaptation.2016.(http://www.who.int)
[120]World Health Organization.Ebola and Marburg virus disease epidemics:preparedness,alert,control and evaluation.2017.(http://who.int/)
[121]World Health Organization.Ebola Virus Disease.2017.(http://www.who.int/)
[122]World Health Organization.Hendra Virus(HeV)Infection.2017.(http://www.who.int/)
[123]World Health Organization.Lassa fever.2016.(http://www.who.int/)
[124]World Health Organization.Marburg Virus Disease.2017.(http://www.who.int/)
[125]World Health Organization.Nipah Virus(NiV)Infection.2017.(http://www.who.int/)
[126]World Health Organization.Rift Valley Fever.2017.(http://www.who.int/)
[127]World Health Organization.Yellow fever situation report.(http://who.int/)
[128]Wu D,Zhang Y,Qiong Z,et al.Chikungunya virus with E1-A226V mutation causing two outbreaks in 2010,Guangdong,China.Virol J,2013,10:174.
[129]Xing X,Guan X,Liu L,et al.Natural Transmission Model for Severe Fever With Thrombocytopenia Syndrome Bunyavirus in Villages of Hubei Province,China.Medicine(Baltimore),2016,95(4):e2533.
[130]Yoshikawa T,Shimojima M,Fukushi S,et al.Phylogenetic and Geographic Relationships of Severe Fever With Thrombocytopenia Syndrome Virus in China,South Korea,and Japan.J Infect Dis,2015,212(6):889-898.
[131]Yu XJ,Liang MF,Zhang SY,et al.Fever with thrombocytopenia associated with a novel bunyavirus in China.N Engl J Med,2011,364(16):1523-1532.
[132]Yun NE,Walker DH.Pathogenesis of Lassa Fever.Viruses,2012,4(10),2031-2048.
[133]Zhang Q,He J,Wu D,et al.Maiden outbreak of chikungunya in Dongguan city,Guangdong province,China:epidemiological characteristics.PLoS One,2012,7(8):e42830.
第三章
[1]边国林,郭延波,王爱红.公共场所军团菌污染现状研究进展.环境与职业医学,2014,31(12):981-984.
[2]陈求扬,林淑芳,梁庆福,等.福建省结核病耐药监测报告.中国防痨杂志,2013,35(7):511-515.
[3]陈文聪,胡朝晖,朱庆义.军团菌病国内流行概况和预防.中华临床医师杂志(电子版),2013,7(02):752-754.
[4]陈扬,胡大春.耐甲氧西林金黄色葡萄球菌基因分型的研究进展.国际检验医学杂志,2014,35(10):1299-1301.
[5]崔亮亮,周连,申涛,等.军团病暴发疫情的感染概况.环境卫生学杂志,2013,3(1):72-76.
[6]董鹏霞,托娅.耐甲氧西林金黄色葡萄球菌感染研究进展.检验医学与临床,2015,12(1):116-118.
[7]杜德超,于岩飞,马彩凤,等.猪链球菌2型不同mrp基因型与毒力的关系.微生物学通报,2016,43(1):147-155.
[8]冯锦姝,张志诚,余淑苑,等.深圳公共场所水系统嗜肺军团菌污染研究.中国卫生工程学,2012,11(1):32-33,36.
[9]高志勇,庄辉.人-猪链球菌病研究进展.中华流行病学杂志.2005,26(9):645-648.(https://www.daowen.com)
[10]何媛.军团菌肺炎.内蒙古中医药,2014,33(26):68-69.
[11]马坚,胡必杰.军团菌肺炎研究进展.中国实用内科杂志,2011,31(12):970-973.
[12]耐甲氧西林金黄色葡萄球菌感染防治专家委员会.耐甲氧西林金黄色葡萄球菌感染防治专家共识.中华实验和临床感染病杂志,2010,4(2):215-223.
[13]耐甲氧西林金黄色葡萄球菌感染防治专家委员会.耐甲氧西林金黄色葡萄球菌感染防治专家共识2011年更新版.中华实验和临床感染病杂志.2011,5(3):66-72.
[14]申晓娜,赵雁林,肖和平.结核分枝杆菌药物敏感性表型检测的研究进展.中国防痨杂志,2013,35(6):463-467.
[15]唐神结,许绍发,李亮.耐药结核病学.北京:人民卫生出版社,2014.
[16]汪华,景怀琦,李红卫,等.江苏省淮北地区肠出血性大肠埃希菌O157:H7感染性腹泻并发急性肾衰的研究.中华流行病学杂志,2004,25(11):938-940.
[17]王黎霞,成诗明,何广学,等.中国结核感染预防控制手册.北京:中国协和医科大学出版社,2010.
[18]肖和平.耐药结核病化学治疗指南.北京:人民卫生出版社,2015.
[19]杨丹丹,邵燕,虞浩,等.江苏省耐药结核病抽样调查研究.南京医科大学学报(自然科学版),2011,(7):1007-1010.
[20]赵思宏,陈愉.军团菌感染诊断方法评析.中国实用内科杂志,2016,32(02):101-104.
[21]卫生部.2000年全国结核病流行病学抽样调查资料汇编.北京:人民卫生出版社,2003.
[22]卫生部.关于印发《肠出血性大肠杆菌O104:H4感染防控方案(试行)》的通知(卫办医政发[2011]87号).2011.
[23]卫生部.全国结核病耐药性基线调查报告(2007～2008).北京:人民卫生出版社,2010.
[24]Agger M,Scheutz F,Villumsen S,et al.Antibiotic treatment of verocytotoxin-producing Escherichia coli(VTEC)infection:a systematic review and a proposal.J Antimicrob Chemother,2015,70(9):2440-2446.
[25]Aung KJM,VanDeun A,DeClercq E,et al.Successful“9-month Bangladesh regimen”for multidrug resistant tuberculosis among over 500 consecutive patients.Int J Tuberc Lung Dis,2014,18(10):1180-1187.
[26]Bae WK,Lee YK,Cho MS,et al.A case of hemolytic uremic syndrome caused by Escherichia coli O104:H4.Yonsei Med J,2006,47(3):437-439.
[27]Bielaszewska M,Mellmann A,Zhang W,et al.Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany,2011:a microbiological study.Lancet Infect Dis,2011,11(9):671-676.
[28]Bielaszewska M1,Mellmann A,Zhang W,et al.Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany,2011:a microbiological study.Lancet Infect Dis,2011,11(9):671-676.
[29]Brooks JT,Sowers EG,Wells JG,et al.Non-O157 Shiga toxin-producing Escherichia coli infections in the United States,1983-2002.J Infect Dis,2005,192:1422-1429.
[30]Buchholz U,Bernard H,Werber D,et al.German outbreak of Escherichia coli O104:H4 associated with sprouts.N Engl J Med,2011,365(19):1763-1770.
[31]Calfee DP,Salgado CD,Milstone AM,et al.Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals:2014 update.Infect Control Hosp Epidemiol,2014,35(Suppl 2):S108-132.
[32]Chang K,Lu W,Wang J,et al.Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay:a meta-analysis.J Infect,2012,64(6):580-588.
[33]Correia AM,Ferreira JS,Borges V,et al.Probable Person-to-Person Transmission of Legionnaires' Disease.New England J Med,2016,374(5):497-498.
[34]ertheim HFL,Nghia HDT,Taylor W,et al.Streptococcus suis:An Emerging Human Pathogen.Clinical Infectious Diseases,2009,48(5):617-625.
[35]Farrokh C,Jordan K,Auvray F,et al.Review of Shiga-toxin-producing Escherichia coli(STEC)and their significance in dairy production.Int J Food Microbiol,2013,162(2):190-212.
[36]Feng Y,Zhang H,Ma Y,et al.Uncovering newly emerging variants of Streptococcus suis,an important zoonotic agent.Trends Microbiol,2010,18(3):124-131.
[37]Feng Y,Zhang H,Wu Z,et al.Streptococcussuis infection.Virulence.2014,5(4):477-497.
[38]Ferens WA,Hovde CJ.Escherichia coli O157:H7:animal reservoir and sources of human infection.Foodborne Pathog Dis,2011,8:465-887.
[39]Fittipaldi N,Segura M,Grenier D,et al.Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcussuis.Future Microbiol,2012,7(2):259-279.
[40]Franz E,van Bruggen AH.Ecology of E.coli O157:H7 and Salmonella enterica in the primary vegetable production chain.Crit Rev Microbiol,2008,34:143-161.
[41]Gorwitz RJ,Kruszon-Moran D,McAllister SK,et al.Changes in the prevalence of nasal colonization with Staphylococcusaureus in the United States,2001-2004.JInfect Dis,2008,197(9):1226-1234.
[42]Gottschalk M,Segura M,Xu J.Streptococcussuis infections in humans:the Chinese experience and the situation in North America.Animal Health Research Reviews,2007,8(01):29-45.
[43]Gould FK,Brindle R,Chadwick PR,et al.Guidelines(2008)for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus(MRSA)infections in the United Kingdom.J Antimicrob Chemother,2009,63:849-861.
[44]Keen JE,Wittum TE,Dunn JR,et al.Shiga-toxigenic Escherichia coli O157 in agricultural fair livestock,United States.Emerg Infect Dis.2006,12(5):780-7866.
[45]Kuaban C,Noeske J,Rieder HL,et al.High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.Int J Tuberc Lung Dis,2015,19(5):517-524.
[46]Lin J,Peng Y,Xu P,et al.Methicillin-Resistant Staphylococcusaureus Nasal Colonization in Chinese Children:A Prevalence Meta-Analysis and Review of Influencing Factors.PLoS One,2016,11(7):e0159728.
[47]Liu C,Bayer A,Cosgrove SE,et al.Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children.CID,2011,52:e18-e55.
[48]Lun ZR,Wang QP,Chen XG,et al.Streptococcus suis:an emerging zoonotic pathogen.Lancet Infect Dis,2007,7(3):201-209.
[49]Mathusa EC,Chen Y,Enache E,et al.Non-O157 Shiga toxin-producing Escherichia coli in foods.J Food Prot,2010,73:1721-1736.
[50]Parsons BD,Zelyas N,Berenger BM,et al.Detection,Characterization,and Typing of Shiga Toxin-Producing Escherichia coli.Front Microbiol,2016,7:478.
[51]Pertel PE,Bernardo P,Fogarty C,et al.Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.Clin Infect Dis,2008,46(8):1142-1151.
[52]Rasko DA,Webster DR,Sahl JW,et al.Origins of the E.coli strain causing an outbreak of hemolytic-uremic syndrome in Germany.N Engl J Med,2011,365(8):709-717.
[53]Rohde H,Qin J,Cui Y,et al.Open-source genomic analysis of Shiga-toxin-producing E.coli O104:H4.N Engl J Med,2011,365(8):718-24.
[54]Samkar AV,Brouwer MC,Schultsz C,et al.Streptococcussuis Meningitis:A Systematic Review and Meta-analysis.PLOS Neglected Tropical Diseases,2015,9(10):e4191.
[55]Segura M,Calzas C,Grenier D,et al.Initial steps of the pathogenesis of the infection caused by Streptococcussuis:fighting against nonspecific defenses.FEBS Lett,2016,590(21):3772-3799.
[56]Segura M.Streptococcussuis vaccines:candidate antigens and progress.Expert Rev Vaccines,2015,14(12):1587-1608.
[57]Thati V,Shivannavar CT,Gaddad SM.Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad.Indian J Med Res,2011,134(5):704-708.
[58]Wang Y,Zou YM,Xie J,et al.Linezolid versus vancomycin for the treatment of suspected methicillinresistant Staphylococcus aureus nosocomial pneumonia:a systematic review employing meta-analysis.Eur J Clin Pharmacol,2015,71:107-115.
[59]World Health Organization.Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis.2014.(http://www.who.int/)
[60]World Health Organization.Global tuberculosis report 2015.(http://www.who.int/)
[61]World Health Organization.Rapid diagnostic test and shorter,cheaper treatment signal new hope for multidrug-resistant tuberculosis patients.2016.(http://www.who.int/)
[62]Yu VL,Stout JE.Community-acquired legionnaires disease:implications for under diagnosis and laboratory testing.Clinical infectious diseases:an official publication of the Infectious Diseases Society of America,2008,46(9):1365-1367.
第四章
[1]陈念,金柯,徐晶晶,等.输入性非洲锥虫病一例.中华传染病杂志,2016,34(5);309-311.
[2]冯耀宇.新发水源性人兽共患寄生虫病的监测和污染源追踪.兽医导刊,2011,10:9.
[3]广州管圆线虫病诊断标准.WS 321-2010.
[4]何战英,王小梅,李锡太,等.北京市5例输入性罗阿丝虫病流行病学.热带病与寄生虫学,2016,14(2):74-76.
[5]李莉莎,林金祥,张榕燕.人体寄生曼氏裂头蚴超过36年报道.中国人兽共患病学报,2009,25(8):830.
[6]裂头蚴病的诊断标准.WS 438-2013.
[7]林国华,颜翠兰,方彦炎,等.广州管圆线虫Ⅰ期幼虫感染河蚬、河蚌实验研究,中国热带医学,2016,16(6):570-573.
[8]蔺西萌,王中全.我国曼氏裂头蚴病的临床特征概述.中国病原生物学杂志,2011,6(6):467-468.
[9]刘和香,张仪,周晓农,等.福寿螺休眠期体内广州管圆线虫生长发育及其感染性的观察研究.中国寄生虫学与寄生虫病杂志,2006,24(4):269-272.
[10]彭东觉,张波,孙志坚,等.不同水温下不同时间对福寿螺体内广州管圆线虫的杀灭作用.中国人兽共患病学报,2009,25(9):882-885.
[11]钱颖骏,李石柱,王强,等.中国输入性美洲锥虫病疫情的快速风险评估.中国寄生虫学与寄生虫病杂志,2013,(1);57-59.
[12]汤林华,许隆祺,陈颖丹.中国寄生虫病防治研究.北京:北京科学技术出版社,2012.
[13]唐贵文,陈艳.不同理化因素对曼氏裂头蚴感染性的影响.中国寄生虫学与寄生虫病杂志,2011,29(5):368-371.
[14]王越,干小仙.曼氏裂头蚴病诊断研究进展.中国人兽共患病学报,2007,23(9):942-944.
[15]危芙蓉,刘和香,吕山,等.用多重PCR技术检测小管福寿螺体内广州管圆线虫幼虫,中国寄生虫学与寄生虫病杂志,2010,28(5):355-358.
[16]吴观陵.人体寄生虫学.第4版.北京:人民卫生出版社,2015.
[17]许隆祺.图说寄生虫学与寄生虫病.北京:北京科技技术出版社,2016.
[18]易平,袁里平,王璋华,等.184例疑似输入性埃及血吸虫病病例回顾性调查.中国血吸虫病防治杂志,2011,23(4):441-442.
[19]张仪,周晓农,刘和香,等.PCR检测大瓶螺体内广州管圆线虫幼虫方法的建立,中国寄生虫学与寄生虫病杂志,2006,24(5):353-355.
[20]郑南才,黄宝明,梁柏年,等.各种化学因素对广州管圆线虫第Ⅲ期幼虫活力的影响,中国自然医学杂志,2007,9(6):457-460.
[21]周晓农.食源性寄生虫病.北京:人民卫生出版社,2009.
[22]朱蓉,许静.我国境外输入性血吸虫病的疫情现状与防控思考.中国血吸虫病防治杂志,2014,26(2):111-114.
[23]Andrade DV,Gollob KJ,Dutra WO.Acute chagas disease:new global challenges for an old neglected disease.PLoS Negl Trop Dis,2014,31;8(7):e3010.
[24]Baldursson S,Karanis P.Waterborne transmission of protozoan parasites:review of world wide outbreaks-an update 2004-2010.Water Res,2011,45:6603-6614.
[25]Büscher P,Cecchi G,Jamonneau V,Priotto G.Human African trypanosomiasis.Lancet,2017,390(10110):2397-2409.
[26]Centers for Diseases Control and Prevention.Cyclosporiasis outbreak investigations—United States,2015.(http://www.cdc.gov/parasites/cyclosporiasis/outbreaks/2015/index)
[27]Centers for Diseases Control and Prevention.“Parasites-cyclosporiasis(Cyclospora infection).Biology”.Global Health-Division of Parasitic Diseases and Malaria Notice.(http://www.cdc.gov/parasites/cyclosporiasis/biology)
[28]Coura JR,Viñas PA,Junqueira AC.Ecoepidemiology,short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries.Mem Inst Oswaldo Cruz,2014,109(7):856-862.
[29]Crump A,Morel CM,Omura S.The onchocerciasis chronicle:from the beginning to the end?Trends Parasitol,2012,28(7):280-288.
[30]Fayer R.Taxonomy and species delimitation in Cryptosporidium.Exp Parasitol,2010,124(1):90-97.
[31]Ferreira LG,de Oliveira MT,Andricopulo AD.Advances and Progress in Chagas Disease Drug Discovery.Curr Top Med Chem,2016,16(20):2290-2302.
[32]Franco JR,Simarro PP,Diarra A,et al.Epidemiology of human African trypanosomiasis.Clin Epidemiol.2014,(6):257-275.
[33]Kennedy PG.Clinical features,diagnosis,and treatment of human African trypanosomiasis(sleeping sickness).Lancet Neurol,2013,12(2):186-194.
[34]Konh Y,Kang SY,Cho SY.Antigenic protein purification of potent antigenic protein from Sparganum by gelatin-affinity chromatography.Koreon J Parasital,1991,29(1):1-7.
[35]Korich DG,Mead JR,Madore MS,et al.Effects of ozone,chlorine dioxide,chlorine,and monochloramine on Cryptosporidium parvum oocyst viability.Appl Environ Microbiol,1990.56(5),1423-1428.
[36]Kupferschmidt K.A worm vaccine,Coming at a snail's pace.Science,2013,339(6119):502-503.
[37]Lai YS,Biedermann P,Ekpo UF,et al.Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa:a systematic review and geostatistical analysis.Lancet Infect Dis,2015,15(8):927-940.
[38]Lapeta J.Cryptosporidiosis and Cryptosporidium species in animals and humans:A thirty colour rainbow?Int J Parasitol,2013,43(12-13):957-970.
[39]Liu SY,Wang L,Zheng HJ et al.Comparative genomics reveals Cyclospora cayetanensis possesses coccidia-like metabolism and invasion components but unique surface antigens.BMC Genomics,2016,17:316-333.
[40]Lv S,Zhou XN,Zhang Y,et,al.The effect of temperature on the development of Angiostrongylus cantonensis(Chen,1935)in Pomacea canaliculata(Lamarck,1822).Parasitol Res,2006,99(5):583-587.
[41]Mekonnen SA,Beissner M,Saar M,et al.O-5S quantitative real-time PCR:a new diagnostic tool for laboratory confirmation of human onchocerciasis.Parasit Vectors,2017,10(1):451.
[42]Nsagha DS,Njunda AL,Assob NJ.et al.Intestinal parasitic infections in relation to CD4(+)T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in Cameroon.BMC Infect Dis,2016,16:9.
[43]Peters W,Pasvol G.Atlas of tropical medicine and parasitology,sixth edition.Elsevier Mosby,London,2011.
[44]Plutzer J,Karanis P.Neglected waterborne parasitic protozoa and their detection in water.Water Research,2016,101:318-332.
[45]Pérez-Molina JA,Molina I.Chagas disease.Lancet,2017,391(10115):82-94.
[46]Sponseller JK,Griffiths JK,Tzipori S.The evolution of respiratory cryptosporidiosis:evidence for transmission by inhalation.Clin Microbiol Rev,2014,27(3):575-586.
[47]Sutherland CS,Yukich J,Goeree R,et al.A literature review of economic evaluations for a neglected tropical disease:human African trypanosomiasis(“sleeping sickness”).PLoS Negl Trop Dis,2015,9(2):e0003397.
[48]Tyzzer,EE.A sporozoan found in the peptic glands of the common mouse.Proc.Soc Exp Biol Med,1907,5(1):12-13.
[49]Wallace P,Geoffrey P.Atlas of tropical medicine and parasitology,6th edition.Mosby:London,Elsevier,2011.
[50]World Health Organization.Control and surveillance of human African trypanosomiasis.World Health Organ Tech Rep Ser,2013,(984):1-237.
[51]Xiao L,Ryan UM,Fayer R,et al.Cryptosporidium tyzzeri and Cryptosporidium pestis:which name is valid?Exp Parasitol,2012,130(3):308-309.
[52]Yadav P,Khalil S,Mirdha BR,et al.Molecular characterization of clinical isolates of Cyclospora cayetanensis from patients with diarrhea in India.Indian J Med Microbiol,2015,33(3):351-356.
第五章
[1]白静,孙云闯,孙葳,等.伴瘙痒症状的Heidenhain变异型克雅病3例报告并文献复习.中国神经精神疾病杂志,2016,42(2):96-99.
[2]陈操,周伟,张宝云,等.2015年中国克雅氏病监测病例特征分析.疾病监测,2016,31(5):365-369.
[3]董小平,洪涛.我国人类朊病毒病检测监测体系建立及相关基础和应用研究.中国预防医学杂志,2010,11(1):11-14.
[4]冯子健.传染病控制手册.北京:中国协和医科大学出版社,2008.
[5]黄勋,范学工.克雅病研究进展.临床内科杂志,2010,27(5):293-295.
[6]李静,梁张,宝福凯,等.莱姆病流行病学研究进展.中国热带医学,2013(8):1035-1038.
[7]石琦,陈操,董小平.进入疯牛病和变异型克雅氏病消除阶段的动物及人类朊病毒病监测.疾病监测,2016,31(5):360-364.
[8]孙继民,刘起勇.埃立克体宿主和媒介的研究进展.中国媒介生物及控制杂志,2007,18(1):76-79.
[9]巫善明,张志勇,张占卿.新发传染病与再发传染病.上海:上海科技教育出版社,2010.
[10]吴凡.输入性及新发传染病防治手册.上海:上海文化出版社,2010.
[11]袁庆虹,何作顺,张海林.人类埃立克体病综述.中国热带医学,2009,9(6):1155-1157.
[12]张丽娟.埃立克体与埃立克体病.微生物与感染,2007,2(4):232-236.
[13]张丽娟.我国人兽共患无形体病防治面临的挑战—诊断与经验治疗.热带病与寄生虫学,2016,14(1):1-2.
[14]张丽娟.中国嗜吞噬细胞无形体及无形体病研究进展.疾病监测,2014,29(5):409-414.
[15]张腾龙,陈志宝,鞠传静,等.朊病毒病治疗的研究进展.中国人兽共患病学报,2015,31(1):64-69.
[16]张文丽,陈志海.我国单核细胞埃立克体病流行特点及防治.中华流行病学杂志,2014,35(8):970-973.
[17]赵高余,陈小萍,张永振.埃立克体和埃立克体病.中华流行病学杂志,2013,34(6):642-646.
[18]卫生部.人粒细胞无形体病预防控制技术指南(试行).卫生部应急发[2008]18号.
[19]Aguero-Rosenfeld ME,Donnarumma L,Zentmaier L,et al.Seroprevalence of antibodies that react with Anaplasmaphagocytophila,the agent of human granulocytic ehrlichiosis,indifferent populations in Westchester County,New York.J Clin Microbiol,2002,40:2612-2615.
[20]Anneleen B,Hadewych J,Hofstede M,et al.Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.N Engl J Med,2016;373(13):1209-1220.
[21]Aucott JN,Crowder LA,Kortte KB.Development of a foundation for a case definition of posttreatment Lyme disease syndrome.International J Infecti Dis.2013;17(6):443-449.
[22]Bakken JS,Dumler S.Human Granulocytic Anaplasmosis.Infect Dis Clin Am,2008,22:433-448.
[23]Blanco JR,Oteo JA.Human granulocyticehrlichiosis in Europe.Clin Microbiol Infect,2002,8:763-72.
[24]Centers for Disease Control and Prevention.Anaplasma phagocytophilum transmitted through blood transfusion—Minnesota,2007.MMWR Morb Mortal Wkly Rep,2008;57:1145-8.
[25]Centers for Disease Control and Prevention.Anaplasmosis.(http://www.cdc.gov/)
[26]Centers for Disease Control and Prevention.Ehrlichiosis.(http://www.cdc.gov/)
[27]Chen C,Dong XP.Epidemiological characteristics of human prion diseases.Infect Dis Poverty,(2016)5:47.
[28]Chen SM,Dumler JS,Bakken JS,et al.Identification of agranulocytotropic Ehrlichia species as the etiologic agent of humandisease.JClin Microbiol,1994;32:589-595.
[29]Dumler JS,Choi KS,Garcia-Garcia JC,et al.Human Granulocytic Anaplasmosis and Anaplasmaphagocytophilum.Emerg Infect Dis,2005,11(12):1828-1834.
[30]Edgar S,Edouard V,Gary P,et al.Diagnosis,Treatment,and Prevention of Lyme Disease,Human Granulocytic Anaplasmosis,and Babesiosis A Review.JAMA,2016;315(16):1767-1777.
[31]Ismail N,Bloch KC,McBride JW.Human Ehrlichiosis and Anaplasmosis.Clin Lab Med,2010,30(1):261-292.
[32]Jereb M,Pecaver B,Tomazic J,et al.Severe human granulocytic.Anaplasmosis transmitted by blood Transfusion.Emerg Infect Dis,2012,18(8)1354-1357.
[33]Joseph D,Kiersten J,Anna E,et al.No Geographic Correlation between Lyme Disease and Death Due to 4 Neurodegenerative Disorders,United States,2001-2010.Emerg Infect Dis,2015.21(11):2036-2039.
[34]Kalantarpour F,Chowdhury I,Wormser GP,et al.Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions.J Clin Microbiol,2000;38:2398-2399.
[35]Nahed Ismail,Karen C.Bloch,Jere W.McBride,Human Ehrlichiosis and Anaplasmosis.Clin Lab Med.2010,30(1):261-292.
[36]Petrovec M,Lotric-Furlan S,Avsic-Zupanc T,et al.Human disease in Europe caused by a granulocytic Ehrlichia species.J Clin Microbiol.1997;35:1556-1559.
[37]Scholz H,Margos G,Der Schum H,et al.High prevalence of genetically diverse Borrelia bavariensis-like strains in Ixodes persulcatus from Selenge Aimag,Mongolia.Ticks and Tick-borne Diseases,2013,4(1/2):89-92.
[38]Scott JD.Borrelia burgdorferi.J Med Entomol,2012,49(2):237.
[39]Tibbles CD,Edlow JA.Does this patient have erythema migrans?JAMA,2007,297(23):2617-2627.
[40]Wormser GP,Dattwyler RJ,Shapiro ED,et al.The clinical assessment,treatment,and prevention of Lyme disease,human granulocytic anaplasmosis,and babesiosis:clinical practice guidelines by the Infectious Diseases Society of America.Clin Infect Dis,2006;43(9):1089-1134.
[41]Wu Q,Liu Z,Wang J,et al.Pathogenic analysis of Borrelia garinii strain SZ isolated from northeastern China.Parasites Vectors,2013,6(1):177.
[42]Yang X,Qin J,Promnares K.et al.Novel microbial virulence factor triggers murine Lyme arthritis.J Infect Dis.2013,207(6):907-918.
[43]Zhang L,Wang Y,Chen C,et al.Isolation of Borrelia burgdorferi inixodes from four counties,in NorthXinjiang.Zhonghua Liuxingbingxue Zazhi.2014,35(3):262-265.
[44]Zhang LC,Wang L,Zhang L,et al.Anaplasma phagocytophilum and Ehrlichiachaffeensis in Yiyuan County,Shandong.Infect Dis Informat,2009;1:21-25.